← back to search

Lauren E. Brown

Boston University · US
Area of research
Molecular Biology · Global and Planetary Change
Research interest
Research interests include Amphibian and Reptile Biology, Phytochemical compounds biological activities, RNA and protein synthesis mechanisms, and Species Distribution and Climate Change.
h-index
34
citations
3,184
works
214
NIH funding
primary concept
email

Recent publications

A chemical screen identifies structurally diverse metal chelators with activity against the fungal pathogen <i>Candida albicans</i>
Microbiology Spectrum 2024cited by 9position: middledoi
BRCA mutational status shapes the stromal microenvironment of pancreatic cancer linking clusterin expression in cancer associated fibroblasts with HSF1 signaling
Nature Communications 2022cited by 79position: middledoi
Identification of structurally re-engineered rocaglates as inhibitors against hepatitis E virus replication
Antiviral Research 2022cited by 15position: middledoi
Defining and navigating macrocycle chemical space
Chemical Science 2021cited by 39position: middledoi
Fungal-Selective Resorcylate Aminopyrazole Hsp90 Inhibitors: Optimization of Whole-Cell Anticryptococcal Activity and Insights into the Structural Origins of Cryptococcal Selectivity
Journal of Medicinal Chemistry 2021cited by 39position: lastdoi
Channeling macrophage polarization by rocaglates increases macrophage resistance to Mycobacterium tuberculosis
iScience 2021cited by 25position: middledoi
Heat Shock Factor 1-dependent extracellular matrix remodeling mediates the transition from chronic intestinal inflammation to colon cancer
Nature Communications 2020cited by 107position: middledoi
Rocaglates Induce Gain-of-Function Alterations to eIF4A and eIF4F
Cell Reports 2020cited by 76position: middledoi
An oxindole efflux inhibitor potentiates azoles and impairs virulence in the fungal pathogen Candida auris
Nature Communications 2020cited by 69position: middledoi
Translation Inhibition by Rocaglates Activates a Species-Specific Cell Death Program in the Emerging Fungal Pathogen Candida auris
mBio 2020cited by 39position: middledoi
Structural basis for species-selective targeting of Hsp90 in a pathogenic fungus
Nature Communications 2019cited by 121position: middledoi
eIF4A supports an oncogenic translation program in pancreatic ductal adenocarcinoma
Nature Communications 2019cited by 113position: middledoi
Amidino-Rocaglates: A Potent Class of eIF4A Inhibitors
Cell chemical biology 2019cited by 77position: middledoi
Design and Synthesis of Fungal-Selective Resorcylate Aminopyrazole Hsp90 Inhibitors
Journal of Medicinal Chemistry 2019cited by 62position: lastdoi
Intercepted Retro-Nazarov Reaction: Syntheses of Amidino-Rocaglate Derivatives and Their Biological Evaluation as eIF4A Inhibitors
Journal of the American Chemical Society 2019cited by 36position: middledoi
Targeting translation initiation by synthetic rocaglates for treating MYC-driven lymphomas
Leukemia 2019cited by 32position: middledoi
Sensitization of renal carcinoma cells to TRAIL-induced apoptosis by rocaglamide and analogs
Scientific Reports 2018cited by 297position: middledoi
Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space
ACS Central Science 2018cited by 43position: middledoi
Inhibiting the oncogenic translation program is an effective therapeutic strategy in multiple myeloma
Science Translational Medicine 2017cited by 72position: middledoi
Total Syntheses of the Isomeric Aglain Natural Products Foveoglin A and Perviridisin B: Selective Excited‐State Intramolecular Proton‐Transfer Photocycloaddition
Angewandte Chemie International Edition 2017cited by 39position: middledoi
Dihydropyrimidine-Thiones and Clioquinol Synergize To Target β-Amyloid Cellular Pathologies through a Metal-Dependent Mechanism
ACS Chemical Neuroscience 2017cited by 17position: middledoi
A Novel Class of Small Molecule Compounds that Inhibit Hepatitis C Virus Infection by Targeting the Prohibitin-CRaf Pathway
EBioMedicine 2015cited by 57position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

John A. Porco · Boston University16 papers (2015–2024)Luke Whitesell · University of Toronto7 papers (2017–2024) · 6 papers (2019–2024)Wenhan Zhang · Amgen (United States)5 papers (2019–2022)Nicole Robbins · McMaster University5 papers (2019–2021)Richard Trilles · Boston University4 papers (2017–2021)Jerry Pelletier · McGill University4 papers (2019–2020)William G. Devine · Northeastern University4 papers (2017–2020) · 3 papers (2019–2020)Emmanuelle V. LeBlanc · Queen's University3 papers (2019–2021)David S. Huang · Foghorn Therapeutics (United States)3 papers (2019–2021)Jennifer Chu · McGill University3 papers (2019–2020)Damian J. Krysan · University of Iowa3 papers (2019–2021)Noelle S. Williams · Southwestern Medical Center2 papers (2020–2021)Wenyu Wang · Xihua University2 papers (2015–2024)Susan Lindquist · Massachusetts Institute of Technology2 papers (2017–2019) · 2 papers (2019–2019)J.C. Pizarro · Tulane University2 papers (2019–2019)Tony T. Wang · University of Virginia2 papers (2015–2019)Françis Robert · McGill University Health Centre2 papers (2019–2020)